<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="ethics">
 <title>Compliance with ethical standards</title>
 <notes notes-type="funding">
  <title>Funding</title>
  <p>The authors are grateful for funding from The Bill and Melinda Gates Foundation (OPP1163327 and OPP1201239 award to David B. Weiner) and National Institutes of Health (R01 AI141236 award to David B. Weiner and U19 AI142777 subaward to Ami Patel). The research described in this manuscript was funded by The Bill and Melinda Gates Foundation (OPP1163327 and OPP1201239 award to David B. Weiner).</p>
 </notes>
 <notes notes-type="COI-statement">
  <title>Conflict of interest</title>
  <p id="Par59">M. B. declares no competing interests. A. P. is listed as an inventor on patents related to DMAbs. D. B. W. has received grant funding, participates in industry collaborations, has received speaking honoraria, and has received fees for consulting, including serving on scientific review committees and board service. Remuneration received by D. B. W. includes direct payments or stock or stock options, and, in the interest of disclosure, he notes potential conflicts associated with this work with Inovio and possibly others. In addition, he has patents on DMAbs and DNA vaccine delivery.</p>
 </notes>
</notes>
